ACET Adicet Bio Inc

Price (delayed)

$8.13

Market cap

$258.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.03

Enterprise value

$53.41M

Highlights
Adicet Bio's equity has surged by 115% QoQ
ACET's EPS has surged by 93% year-on-year and by 79% since the previous quarter
The quick ratio has soared by 105% from the previous quarter but it has plunged by 70% YoY
Adicet Bio's revenue has shrunk by 75% QoQ
The gross profit has dropped by 75% since the previous quarter

Key stats

What are the main financial stats of ACET
Market
Shares outstanding
31.81M
Market cap
$258.64M
Enterprise value
$53.41M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.09
Price to sales (P/S)
47.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.98
Earnings
Revenue
$4.46M
EBIT
-$50.69M
EBITDA
-$47.76M
Free cash flow
-$43.31M
Per share
EPS
-$1.03
Free cash flow per share
-$1.66
Book value per share
$7.43
Revenue per share
$0.17
TBVPS
$10.05
Balance sheet
Total assets
$282.07M
Total liabilities
$45.81M
Debt
$21.2M
Equity
$236.26M
Working capital
$203.92M
Liquidity
Debt to equity
0.09
Current ratio
9.1
Quick ratio
9.06
Net debt/EBITDA
4.3
Margins
EBITDA margin
-1,071.6%
Gross margin
100%
Net margin
-1,136.5%
Operating margin
-1,122.1%
Efficiency
Return on assets
-30.7%
Return on equity
-38%
Return on invested capital
-236.9%
Return on capital employed
-19.7%
Return on sales
-1,137.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
-0.85%
1 week
4.23%
1 month
-11.53%
1 year
230.49%
YTD
-42.14%
QTD
-20.99%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$4.46M
Gross profit
$4.46M
Operating income
-$50.01M
Net income
-$50.66M
Gross margin
100%
Net margin
-1,136.5%
Adicet Bio's revenue has shrunk by 75% QoQ
The gross profit has dropped by 75% since the previous quarter
The company's net income fell by 38% QoQ and by 15% YoY
ACET's operating income is down by 28% from the previous quarter

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
1.09
P/S
47.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.98
ACET's EPS has surged by 93% year-on-year and by 79% since the previous quarter
Adicet Bio's equity has surged by 115% QoQ
ACET's price to book (P/B) is 27% lower than its last 4 quarters average of 1.5
Adicet Bio's revenue has shrunk by 75% QoQ

Efficiency

How efficient is Adicet Bio business performance
ACET's ROE is up by 46% YoY and by 3.3% QoQ
Adicet Bio's return on assets has increased by 27% YoY and by 4.4% QoQ
Adicet Bio's ROIC has decreased by 2.2% from the previous quarter

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
The quick ratio has soared by 105% from the previous quarter but it has plunged by 70% YoY
ACET's current ratio has surged by 104% since the previous quarter but it has dropped by 70% year-on-year
Adicet Bio's debt is 91% lower than its equity
Adicet Bio's equity has surged by 115% QoQ
ACET's debt to equity has shrunk by 55% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.